glp-1 resistant food research GLP-1-directed NMDA receptor antagonism for obesity treatment GLP-1 Food Landscape: 4 Trends

This article reviews: Definition Mechanism of action Experimentally observed benefits Dosages used in scientific studies Reported side effects in laboratory settings All references below relate to experimental or preclinical research models

This metabolic reprogramming not only supports cell proliferation but also elevates intracellular S-adenosylmethionine (SAM) levels, promoting epigenetic alterations and ultimately inducing the acquisition of NEPC characteristics ( PLK1 is highly expressed in high-grade prostate cancer and induces PHGDH degradation by phosphorylating residues Ser512, Ser513 and Ser517

But despite all of the promise, GLP-1 medications often come with frustrating gastrointestinal (GI) side effects

The most common use is for people who are overweight or obese and who have failed to lose weight through diet and exercise alone

Given the ease in accessing blood samples, blood-based biomarkers are frequently used as measures of REDOX state (e.g., refs